Related Experiment Videos
[The "omics" are coming--one gene is not enough anymore]
1Haartman-instituutti ja HYKS-laboratoriodiagnostiikka Biomedicum Helsinki 00014 Helsingin yliopisto.
Duodecim; Laaketieteellinen Aikakauskirja
|September 21, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
TIM3 blockade with hypomethylating therapy restores NK-cell and cytotoxic CD4+ T-cell activity in patients with AML or MDS.
Cancer immunology research·2026
Association Between Obesity and Sex-Related Survival Difference in Lung Cancer.
JCO clinical cancer informatics·2026
Characteristics, treatment and survival of patients with chondrosarcoma in five European countries: a DARWIN EU® cohort study.
Acta oncologica (Stockholm, Sweden)·2026
Assessing Overall Survival Benefits in Advanced Cancers: The Role of External Comparator Cohort Studies with Real-World Data.
Clinical pharmacology and therapeutics·2026
Comorbidities, medication use, and overall survival in eight cancers: a multinational cohort study of 1.7 million patients across Europe.
The Lancet regional health. Europe·2026
Update on Current Care Guideline: Psoriasis (skin and joints).
Duodecim; laaketieteellinen aikakauskirja·2017
FOUR score in monitoring the level of consciousness of an intensive care patient: first experience of the use of the Finnish language version.
Duodecim; laaketieteellinen aikakauskirja·2017
Discussing a serious illness with a patient and family.
Duodecim; laaketieteellinen aikakauskirja·2017
Invasive treatment of superficial veins of the lower extremities.
Duodecim; laaketieteellinen aikakauskirja·2017
When should a drain be left in the abdominal cavity upon surgery?
Duodecim; laaketieteellinen aikakauskirja·2017
Diagnostics and current care of myasthenia gravis.
Duodecim; laaketieteellinen aikakauskirja·2017
Ascl1 Represses Müller Glial and Promotes Rod Photoreceptor Fate Through Repressing Notch Signaling in Late Retinal Progenitor Cells.
Investigative ophthalmology & visual science·2026